Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)

Clinical trial NCT00514488 · COMPLETED

Trial details

NCT number: NCT00514488
Sponsor: University of Bologna
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2004-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.